Show
Sort by
-
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)
-
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
-
Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International Berlin-Frankfurt-Munster AML-study group
-
EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells
-
A multilocus technique for risk evaluation of patients with neuroblastoma
-
Downregulation of miR-449a is essential for the survival of EVI1 positive leukemic cells through modulation of NOTCH1 and BCL2